Inhibitors of hCAP18/LL-37 for use in the treatment of breast cancer

Details for Australian Patent Application No. 2007251359 (hide)

Owner Lipopeptide AB

Inventors Weber, Gunther; Stahle, Mona

Agent Griffith Hack

Pub. Number AU-A-2007251359

PCT Pub. Number WO2007/132175

Priority 0608797.7 04.05.06 GB

Filing date 4 May 2007

Wipo publication date 22 November 2007

International Classifications

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

A61K 31/7088 (2006.01) - Compounds having three or more nucleosides or nucleotides

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

C07K 16/22 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/30 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

4 December 2008 PCT application entered the National Phase

  PCT publication WO2007/132175 Priority application(s): WO2007/132175

12 May 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007251362-Combination therapy product and uses thereof

2007251351-Novel fetal markers for prenatal diagnosis and monitoring